Literature DB >> 14587068

Pinacyanol as effective probe of fibrillar beta-amyloid peptide: comparative study with Congo Red.

Raimon Sabaté1, Joan Estelrich.   

Abstract

The binding of pinacyanol (PIN), a cationic cyanine dye, to beta-amyloid fibrils (Abeta), which are associated with Alzheimer disease, was quantified by absorption spectrophotometry to measure the concentration of PIN bound to Abeta as a function of the Abeta concentration or by means of the separation of free PIN from bound PIN by centrifugation and subsequent analysis of the supernatant by visible-absorption spectrophotometry. Both methods gave equivalent results. The stoichiometry of PIN binding to Abeta was 1, and the curve representing the concentration effect of Abeta on the concentration of a dye-Abeta complex showed a biphasic curve instead of the hyperbolic curve that is characteristic of weak ligand-macromolecule interactions [e.g., as shown by Congo Red (CR)]). This and the fact that a Scatchard plot could not be fitted to the experimental data suggested that PIN binds tightly to Abeta. A comparison to the interaction of CR with Abeta led us to conclude that PIN is more sensitive than CR. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587068     DOI: 10.1002/bip.10485

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  5 in total

1.  Potency of a tau fibrillization inhibitor is influenced by its aggregation state.

Authors:  Erin E Congdon; Mihaela Necula; Robert D Blackstone; Jeff Kuret
Journal:  Arch Biochem Biophys       Date:  2007-05-25       Impact factor: 4.013

2.  PrP(106-126) does not interact with membranes under physiological conditions.

Authors:  Sónia Troeira Henriques; Leonard Keith Pattenden; Marie-Isabel Aguilar; Miguel A R B Castanho
Journal:  Biophys J       Date:  2008-05-09       Impact factor: 4.033

Review 3.  The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.

Authors:  Mark R Hellmich; Ciro Coletta; Celia Chao; Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

4.  Amyloid-β probes: Review of structure-activity and brain-kinetics relationships.

Authors:  Todd J Eckroat; Abdelrahman S Mayhoub; Sylvie Garneau-Tsodikova
Journal:  Beilstein J Org Chem       Date:  2013-05-28       Impact factor: 2.883

5.  Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs.

Authors:  Alba Espargaró; Aina Medina; Ornella Di Pietro; Diego Muñoz-Torrero; Raimon Sabate
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.